McKesson Corporation is expanding its drug development and commercialization capacity to the tune of $2.25 billion. | The ...

Imagine being told that everyone needs to wear one specific pair of low-riding jeans at all times regardless of their age, body configuration, surroundings, or life situation. This could leave you ...

McKesson believes that the deal will support its clinical research and biopharmaceutical commercialisation services.

Precision medicine promises to tailor health care to the individual. But what happens when entire communities are left out of the data that drives that tailoring? When I embarked on cardiovascular ...

A person’s mental health situation can depend on a whole system of factors, ranging from economic to environmental to social to behavioral to biological. (Photo: Getty) You wouldn’t simply wear the ...

Epione is an AI- and robotic-assisted percutaneous ablation platform that integrates every step of the procedure — planning, ...

Tempus AI, Inc. made a timely move to acquire the Personalis cancer monitoring tests to advance AI-driven precision medicine.

Precision Neuroscience is testing its brain-computer interface in human patients at the Mount Sinai Health System in New York City. As CNBC watched from an operating room in April, the company set a ...

The autonomous spraying and seeding drone is expected to begin field testing in Arizona within weeks, expanding ZenaTech Inc.